BOSTON--(BUSINESS WIRE)--Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the appointment of Gary Bridger,...
BOULDER, Colo.--(BUSINESS WIRE)--OnKure, Inc., a clinical-stage biopharmaceutical company discovering and developing the next generation of oncology precision medicines, today announced the appointment of Nicholas...
WASHINGTON--(BUSINESS WIRE)--CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the appointment of Charles R. Bridges, M.D., Sc.D., as...
WATERTOWN, Mass.--(BUSINESS WIRE)--Exo Therapeutics, Inc., a company pioneering the discovery and development of small molecules that can reprogram protein targets through binding to exosites,...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with...
NEW YORK & SUZHOU & SHANGHAI, China--(BUSINESS WIRE)--TandemAI, a technology company focused on transforming drug discovery infrastructure, today announced two key appointments to its...
Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.
